MOURA DUBEUX (MDNE3) Main Indicators
Basic Data - MDNE3
| Company | MOURA DUBEUX |
| Corporate Name | MOURA DUBEUX ENGENHARIA S/A |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Compra e venda de imóveis. locação. desmembramento ou loteamento de terrenos. incorporação imobiliária ou construção de imóveis destinados à venda. participação em outras sociedades. |
| Share | MDNE3 |
| Quote Date | 04/02/2025 |
| Share Type | ON |
| Last Closing | R$ 15.52 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 10.03 M |
| Last Statement | DFP - 12/31/2024 |
| Sector | Consumo Cíclico |
| Subsector | Construção Civil |
| Segment | Incorporações |
| Participation Indexes | GPTW, IBRA, ICON, IGC, IGCT, IGNM, IMOB, INDX, ITAG, SMLL |
| Updated 04/03/2025 | |
Relative Prices - MDNE3
| Price/Earnings | 5.24 |
| Price/SBV | 0.86 |
| Price/Net Sales | 0.84 |
| Price/CFO | 201.62 |
| Price/FCF | -73.39 |
| Price/Total Assets | 0.32 |
| Price/EBIT | 5.31 |
| Price/Working Capital | 1.14 |
| Price/NCAV | -0.91 |
| EV/EBIT | 6.04 |
| EV/EBITDA | 5.80 |
| EV/Net Sales | 0.95 |
| EV/CFO | 229.21 |
| EV/FCF | -83.43 |
| EV/Total Assets | 0.36 |
| Company Market Cap | R$ 1.32 B |
| Enterprise Value | R$ 1.50 B |
| Current Financial Statement Date | 12/31/2024 |
| Current Share Price | R$ 15.52 |
| Share Price Date | 04/02/2025 |
| Dividend Yield | 4.19% |
| Updated 04/03/2025 | |
Income Statement - MDNE3
| Net Revenue | R$ 1.57 B |
| Gross Result | R$ 526.61 M |
| EBIT | R$ 247.95 M |
| Depreciation and Amortization | - R$ 10.53 M |
| EBITDA | R$ 258.48 M |
| Net Profit | R$ 251.49 M |
| Net Profit/Share | R$ 2.96 |
| Updated 03/19/2025 | |
| Net Revenue | R$ 367.71 M |
| Gross Result | R$ 115.94 M |
| EBIT | R$ 41.80 M |
| Depreciation and Amortization | - R$ 2.75 M |
| EBITDA | R$ 44.55 M |
| Net Profit | R$ 45.05 M |
| Profit/Share | R$ 0.53 |
| Updated 03/19/2025 | |
Price and Volume Behavior - MDNE3
| Lowest Price 52 weeks | R$ 9.72 |
| Highest Price 52 weeks | R$ 15.94 |
| Variation 2025 | 46.55% |
| Variation 1 year | 24.69% |
| Variation 2 years(total) | 223.93% |
| Variation 2 years(yearly) | 79.55% |
| Variation 3 years(total) | 138.19% |
| Variation 3 years(yearly) | 33.48% |
| Variation 4 years(total) | 91.00% |
| Variation 4 years(yearly) | 17.53% |
| Variation 5 years(total) | 200.49% |
| Variation 5 years(yearly) | 24.60% |
| Average Daily Volume (3 months) | R$ 6.81 M |
| Updated 04/03/2025 | |
Returns and Margins - MDNE3
| Return on Initial Tangible Capital | 6.09% |
| Return on Initial Invested Capital | 11.50% |
| Pre-Tax Return on Initial Tangible Capital | 9.23% |
| Pre-Tax Return on Initial Invested Capital | 17.42% |
| Return on Initial Shareholder´s Equity | 18.75% |
| Return on Initial Asset | 7.31% |
| Gross Margin | 33.54% |
| Net Margin | 16.02% |
| EBIT Margin | 15.79% |
| EBITDA Margin | 16.46% |
| Initial Asset Turnover | 0.46 |
| Financial Leverage | 2.69 |
| Liabilities/Net Worth | 1.69 |
| Net Debt/EBITDA | 0.70 |
| Updated 03/19/2025 | |
Balance Sheet - MDNE3
| Cash and Cash Equivalents | R$ 331.07 M |
| Total Assets | R$ 4.15 B |
| Short-Term Debt | R$ 171.00 thousand |
| Long-Term Debt | R$ 511.24 M |
| Gross Debt | R$ 511.41 M |
| Net Debt | R$ 180.34 M |
| Shareholder´s Equity | R$ 1.54 B |
| Share Book Value | R$ 18.14 |
| Common Shares | 84,909,375 |
| Preferred Shares | 0 |
| Total | 84,909,375 |
| Common Shares in Treasury | 1,096,048 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 1,096,048 |
| Common Shares (Except Treasury) | 83,813,327 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 83,813,327 |
| Updated 03/19/2025 | |
Cash Flow - MDNE3
| Operating Cash Flow | R$ 6.54 M |
| Cash Flow from Investments | - R$ 53.60 M |
| Financing Cash Flow | R$ 121.02 M |
| Increase (Reduction) in Cash and Equivalents | R$ 73.96 M |
| Updated 03/19/2025 | |
| Operating Cash Flow | R$ 25.66 M |
| Cash Flow from Investments | R$ 21.51 M |
| Financing Cash Flow | - R$ 32.97 M |
| Increase (Reduction) in Cash and Equivalents | R$ 14.20 M |
| Updated 03/19/2025 | |
Experimental - MDNE3
| CAPEX 3 months | - R$ 5.11 M |
| Free Cash Flow 3 months | R$ 20.55 M |
| CAPEX 12 months | - R$ 24.49 M |
| Free Cash Flow 12 months | - R$ 17.96 M |
| Updated 03/19/2025 | |